Is the New Infant Jarvik 2015 Suitable for Patients: In Vitro Study Using a Hybrid Simulator

Arianna Di Molfetta, Krzysztof Zielinski, Gianfranco Ferrari, Macej Kozarski, Piotr Okrzeja, Roberta Iacobelli, Sergio Filippelli, Gianluigi Perri, Marek Darowski, Massimo Massetti, Robert Jarvik, Antonio Amodeo

Research output: Contribution to journalArticle

Abstract

Our aim was to study the feasibility of implanting the Infant Jarvik 2015 in patients weighing less than 8 kg. The Infant Jarvik 2015 left ventricular assist device (LVAD) was tested in a hybrid simulator of the cardiovascular system reproducing specific patients' hemodynamics for different patient weights (2-7 kg). For each weight, the sensitivity of the pump to different circulatory parameters (peripheral resistance, left ventricular elastance, right ventricular elastance, heart rate, and heart filling characteristics) has been tested repeating for each experiment a pump ramp (10 000-18 000 rpm). The increase in the pump speed causes a decrease (increase) in the left (right) atrial pressure, an increase (decrease) in the arterial systemic (pulmonary) pressure, an increase in the right ventricular pressure, a decrease (increase) in the left (right) ventricular volume, a decrease in the left ventricular cardiac output, an increase in the LVAD output and an increase in the right ventricular cardiac output (total cardiac output). Suction was observed for lower weight patients and for higher pump speed in the case of vasodilation, left ventricular recovery, bradycardia, right ventricular failure, and left ventricular hypertrophy. Backflow was observed in the case of left ventricular recovery at lower pump speed. In the hybrid simulator, the Infant Jarvik 2015 could be suitable for the implantation in patients lower than 8 kg because of the stability of the device respect to the cardio/circulatory changes (low frequency of suction and backflow) and because of the capability of the device to maintain adequate patient hemodynamics.

Original languageEnglish
Pages (from-to)E1-E8
Number of pages8
JournalArtificial Organs
Volume43
Issue number1
DOIs
Publication statusE-pub ahead of print - 2018

Fingerprint

Simulators
Pumps
Left ventricular assist devices
Cardiac Output
Hemodynamics
Heart-Assist Devices
Suction
Weights and Measures
Recovery
Cardiovascular system
Weighing
Equipment and Supplies
Architectural Accessibility
Atrial Pressure
Feasibility Studies
Left Ventricular Hypertrophy
Ventricular Pressure
Bradycardia
Cardiovascular System
Vasodilation

Cite this

Di Molfetta, A., Zielinski, K., Ferrari, G., Kozarski, M., Okrzeja, P., Iacobelli, R., ... Amodeo, A. (2018). Is the New Infant Jarvik 2015 Suitable for Patients: In Vitro Study Using a Hybrid Simulator. Artificial Organs, 43(1), E1-E8. https://doi.org/10.1111/aor.13302

Is the New Infant Jarvik 2015 Suitable for Patients : In Vitro Study Using a Hybrid Simulator. / Di Molfetta, Arianna; Zielinski, Krzysztof; Ferrari, Gianfranco; Kozarski, Macej; Okrzeja, Piotr; Iacobelli, Roberta; Filippelli, Sergio; Perri, Gianluigi; Darowski, Marek; Massetti, Massimo; Jarvik, Robert; Amodeo, Antonio.

In: Artificial Organs, Vol. 43, No. 1, 2018, p. E1-E8.

Research output: Contribution to journalArticle

Di Molfetta, A, Zielinski, K, Ferrari, G, Kozarski, M, Okrzeja, P, Iacobelli, R, Filippelli, S, Perri, G, Darowski, M, Massetti, M, Jarvik, R & Amodeo, A 2018, 'Is the New Infant Jarvik 2015 Suitable for Patients: In Vitro Study Using a Hybrid Simulator', Artificial Organs, vol. 43, no. 1, pp. E1-E8. https://doi.org/10.1111/aor.13302
Di Molfetta A, Zielinski K, Ferrari G, Kozarski M, Okrzeja P, Iacobelli R et al. Is the New Infant Jarvik 2015 Suitable for Patients: In Vitro Study Using a Hybrid Simulator. Artificial Organs. 2018;43(1):E1-E8. https://doi.org/10.1111/aor.13302
Di Molfetta, Arianna ; Zielinski, Krzysztof ; Ferrari, Gianfranco ; Kozarski, Macej ; Okrzeja, Piotr ; Iacobelli, Roberta ; Filippelli, Sergio ; Perri, Gianluigi ; Darowski, Marek ; Massetti, Massimo ; Jarvik, Robert ; Amodeo, Antonio. / Is the New Infant Jarvik 2015 Suitable for Patients : In Vitro Study Using a Hybrid Simulator. In: Artificial Organs. 2018 ; Vol. 43, No. 1. pp. E1-E8.
@article{86f91f63fb9a4ccd8f62596f96cd3b0d,
title = "Is the New Infant Jarvik 2015 Suitable for Patients: In Vitro Study Using a Hybrid Simulator",
abstract = "Our aim was to study the feasibility of implanting the Infant Jarvik 2015 in patients weighing less than 8 kg. The Infant Jarvik 2015 left ventricular assist device (LVAD) was tested in a hybrid simulator of the cardiovascular system reproducing specific patients' hemodynamics for different patient weights (2-7 kg). For each weight, the sensitivity of the pump to different circulatory parameters (peripheral resistance, left ventricular elastance, right ventricular elastance, heart rate, and heart filling characteristics) has been tested repeating for each experiment a pump ramp (10 000-18 000 rpm). The increase in the pump speed causes a decrease (increase) in the left (right) atrial pressure, an increase (decrease) in the arterial systemic (pulmonary) pressure, an increase in the right ventricular pressure, a decrease (increase) in the left (right) ventricular volume, a decrease in the left ventricular cardiac output, an increase in the LVAD output and an increase in the right ventricular cardiac output (total cardiac output). Suction was observed for lower weight patients and for higher pump speed in the case of vasodilation, left ventricular recovery, bradycardia, right ventricular failure, and left ventricular hypertrophy. Backflow was observed in the case of left ventricular recovery at lower pump speed. In the hybrid simulator, the Infant Jarvik 2015 could be suitable for the implantation in patients lower than 8 kg because of the stability of the device respect to the cardio/circulatory changes (low frequency of suction and backflow) and because of the capability of the device to maintain adequate patient hemodynamics.",
author = "{Di Molfetta}, Arianna and Krzysztof Zielinski and Gianfranco Ferrari and Macej Kozarski and Piotr Okrzeja and Roberta Iacobelli and Sergio Filippelli and Gianluigi Perri and Marek Darowski and Massimo Massetti and Robert Jarvik and Antonio Amodeo",
note = "{\circledC} 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.",
year = "2018",
doi = "10.1111/aor.13302",
language = "English",
volume = "43",
pages = "E1--E8",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Is the New Infant Jarvik 2015 Suitable for Patients

T2 - In Vitro Study Using a Hybrid Simulator

AU - Di Molfetta, Arianna

AU - Zielinski, Krzysztof

AU - Ferrari, Gianfranco

AU - Kozarski, Macej

AU - Okrzeja, Piotr

AU - Iacobelli, Roberta

AU - Filippelli, Sergio

AU - Perri, Gianluigi

AU - Darowski, Marek

AU - Massetti, Massimo

AU - Jarvik, Robert

AU - Amodeo, Antonio

N1 - © 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

PY - 2018

Y1 - 2018

N2 - Our aim was to study the feasibility of implanting the Infant Jarvik 2015 in patients weighing less than 8 kg. The Infant Jarvik 2015 left ventricular assist device (LVAD) was tested in a hybrid simulator of the cardiovascular system reproducing specific patients' hemodynamics for different patient weights (2-7 kg). For each weight, the sensitivity of the pump to different circulatory parameters (peripheral resistance, left ventricular elastance, right ventricular elastance, heart rate, and heart filling characteristics) has been tested repeating for each experiment a pump ramp (10 000-18 000 rpm). The increase in the pump speed causes a decrease (increase) in the left (right) atrial pressure, an increase (decrease) in the arterial systemic (pulmonary) pressure, an increase in the right ventricular pressure, a decrease (increase) in the left (right) ventricular volume, a decrease in the left ventricular cardiac output, an increase in the LVAD output and an increase in the right ventricular cardiac output (total cardiac output). Suction was observed for lower weight patients and for higher pump speed in the case of vasodilation, left ventricular recovery, bradycardia, right ventricular failure, and left ventricular hypertrophy. Backflow was observed in the case of left ventricular recovery at lower pump speed. In the hybrid simulator, the Infant Jarvik 2015 could be suitable for the implantation in patients lower than 8 kg because of the stability of the device respect to the cardio/circulatory changes (low frequency of suction and backflow) and because of the capability of the device to maintain adequate patient hemodynamics.

AB - Our aim was to study the feasibility of implanting the Infant Jarvik 2015 in patients weighing less than 8 kg. The Infant Jarvik 2015 left ventricular assist device (LVAD) was tested in a hybrid simulator of the cardiovascular system reproducing specific patients' hemodynamics for different patient weights (2-7 kg). For each weight, the sensitivity of the pump to different circulatory parameters (peripheral resistance, left ventricular elastance, right ventricular elastance, heart rate, and heart filling characteristics) has been tested repeating for each experiment a pump ramp (10 000-18 000 rpm). The increase in the pump speed causes a decrease (increase) in the left (right) atrial pressure, an increase (decrease) in the arterial systemic (pulmonary) pressure, an increase in the right ventricular pressure, a decrease (increase) in the left (right) ventricular volume, a decrease in the left ventricular cardiac output, an increase in the LVAD output and an increase in the right ventricular cardiac output (total cardiac output). Suction was observed for lower weight patients and for higher pump speed in the case of vasodilation, left ventricular recovery, bradycardia, right ventricular failure, and left ventricular hypertrophy. Backflow was observed in the case of left ventricular recovery at lower pump speed. In the hybrid simulator, the Infant Jarvik 2015 could be suitable for the implantation in patients lower than 8 kg because of the stability of the device respect to the cardio/circulatory changes (low frequency of suction and backflow) and because of the capability of the device to maintain adequate patient hemodynamics.

U2 - 10.1111/aor.13302

DO - 10.1111/aor.13302

M3 - Article

C2 - 30398290

VL - 43

SP - E1-E8

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 1

ER -